Rhythm Pharmaceuticals, Inc. (RYTM) Thursday said it has priced its upsized public offering of 2.06 million shares at $85 per share.
The company has also granted the underwriters a 30-day option to purchase up to an additional 308,823 shares.
The gross proceeds from the offering, which is expected to close by July 11, are estimated to be about $175 million.
Morgan Stanley, BofA Securities, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.